Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2025-12-25 @ 4:17 AM
NCT ID:
NCT04121520
Eligibility Criteria:
Inclusion Criteria:
Eligible participants must meet the following criteria:
1. aged between 18-75 years, no restriction on gender;
2. clinically and/or pathologically diagnosed sinusoidal cirrhosis;
3. with written informed consent
4. scheduled to undergo HVPG measurement according to the following indications: 1) assessment of the efficacy of primary and secondary prophylactic drugs for gastroesophageal variceal bleeding; 2) predicting the risk of gastroesophageal variceal bleeding and guiding the selection of the treatment regimens; 3) predicting of risk, progression, and clinical outcomes of decompensation events in cirrhosis; 4) evaluation of the efficacy of new drugs; 5) evaluation of the accuracy of new non-invasive techniques; diagnosis and differential diagnosis of types of portal hypertension.
Exclusion Criteria:
Those cases that meet any of the following criteria should be excluded:
1. contradictions for HVPG measurement;
2. pregnant or lactating woman;
3. severe coagulopathy (international normalized ratio\>5);
4. severe heart, lung, or kidney disease.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04121520
Study Brief:
Protocol Section:
NCT04121520